Article Versions Notes

Krishnarajah G, Divino V, Postma MJ, Pelton SI, Anupindi VR, DeKoven M, Mould-Quevedo J. Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018–19 Influenza Season in the United States. Vaccines. 2021; 9(2):80. https://doi.org/10.3390/vaccines9020080

Krishnarajah, Girishanthy, Victoria Divino, Maarten J. Postma, Stephen I. Pelton, Vamshi Ruthwik Anupindi, Mitch DeKoven, and Joaquin Mould-Quevedo. 2021. "Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018–19 Influenza Season in the United States" Vaccines 9, no. 2: 80. https://doi.org/10.3390/vaccines9020080

Krishnarajah, G., Divino, V., Postma, M. J., Pelton, S. I., Anupindi, V. R., DeKoven, M., & Mould-Quevedo, J. (2021). Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018–19 Influenza Season in the United States. Vaccines, 9(2), 80. https://doi.org/10.3390/vaccines9020080